Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3014959	s-toxoab	— (—)	5151	6567	100.00%	Distribution not available
3014959	s-toxoabg	— (—)	4567	5703	100.00%	Distribution not available
3014959	s-toxoabg	iu/ml (—)	498	567	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Enlarged lymph nodes

424

539

8.26

313.05

2.3

2.6

—

Dental caries

776

898

8.75

307.65

2.4

—

Secondary hypertension

456

174

29.40

307.65

2.3

2.6

—

Glomerular diseases

654

638

11.06

307.65

2.3

2.5

—

Glomerular disorders in diseases classified elsewhere

498

386

14.24

307.65

2.3

2.4

—

Myeloid leukaemia

212

37.04

307.65

2.7

2.4

—

Liquid cancers, helper endpoint

921

887

9.46

307.65

2.7

2.3

—

Extracorporeal dialysis

583

200

38.47

307.65

2.3

2.4

—

Nephropathy related operations

1157

326

45.66

307.65

2.3

2.4

—

Bacterial infection, other or unspecified

986

1551

5.51

307.65

2.5

2.4

—

Other septicaemia

640

982

6.44

307.65

2.6

2.4

—

Renal failure

1244

951

12.16

307.65

2.3

—

ILD medications

1993

2682

4.11

307.65

2.4

2.5

—

Dialysis, with operation codes

1130

324

43.86

307.65

2.3

2.4

—

All kidney diseases

1613

3272

3.43

307.65

2.4

2.5

—

Chronic kidney disease

1089

598

19.19

307.65

2.3

2.4

—

Dialysis

450

109

57.98

307.65

2.3

2.4

—

Septicaemia

692

1112

5.97

307.65

2.5

2.4

—

Fever of other and unknown origin

1073

2069

4.73

307.65

2.5

—

Other bacterial diseases

1390

2613

3.64

307.65

2.5

2.4

—

Disorders resulting from impaired renal tubular function

278

104

33.38

307.65

2.3

2.4

—

Preparatory care for dialysis

398

122

42.97

307.65

2.2

2.4

—

Other dialysis

352

52.38

307.65

2.3

2.4

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1993

2668

4.99

307.65

2.5

2.4

—

Care involving dialysis

826

195

56.28

307.65

2.3

2.4

—

Transplanted organ and tissue status

1583

231

110.60

307.65

2.6

2.3

—

All chronic kidney diseases

1260

1414

7.56

307.65

2.3

2.5

—

Persons encountering health services for specific procedures and health care

1781

3091

3.52

307.65

2.4

2.5

—

Bacterial infection, other or unspecified

950

1405

6.03

307.65

2.5

2.4

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1557

3045

3.59

307.65

2.4

2.5

—

Heart failure, not strict

1327

1472

6.29

307.65

2.3

2.5

—

Caries of dentine

672

780

8.83

307.65

2.4

—

First line medication for Crohn's disease

1817

2721

3.67

307.65

2.4

2.5

—

Primary_lymphoid and hematopoietic malignant neoplasms

794

594

14.33

307.65

2.7

2.3

—

ILD medications: immunosuppressive drugs

1876

2159

8.44

307.65

2.5

—

Failure and rejection of transplanted organs and tissues

215

83.44

307.65

2.9

2.3

—

L04AA Selective immunosuppressants

1280

794

18.22

307.65

2.3

2.5

—

ILD medications: prednisolone, methylprednisolone, prednisone

1889

2625

4.11

307.65

2.4

2.5

—

Renal tubulo-interstitial diseases

1498

2956

3.85

307.65

2.3

2.5

—

Explicit Sepsis

735

1371

5.13

307.65

2.6

2.5

—

Acute renal failure

450

454

10.33

307.65

2.4

—

Donors of organs and tissues

226

69.45

307.65

3.1

2.5

—

Kidney transplant status

925

188

88.91

307.65

2.3

2.5

—

L04AD Calcineurin inhibitors

1419

330

61.99

307.65

2.4

—

Other bacterial diseases

1428

2933

3.14

298.53

2.5

—

Cytomegalovirus infection, IBD co-morbidity

204

31.81

297.80

2.5

2.3

—

Other/unspecified cytomegaloviral diseases

196

36.86

297.75

2.5

2.4

—

Cytomegaloviral disease

205

28.80

289.27

2.5

2.4

—

Implicit bacterial Sepsis

572

938

5.52

279.84

2.4

2.3

—

Aplastic and other anaemias

647

1267

4.86

279.32

2.4

—

Bacterial Sepsis

651

1146

4.96

278.93

2.4

—

Other disorders of kidney and ureter

344

396

9.20

275.94

2.3

2.4

—

Non-Hodgkin lymphoma, all, including Hilmo

289

262

11.56

275.08

2.5

2.3

—

Implicit bacterial Sepsis

599

1044

5.06

263.71

2.4

—

Cystic kidney disease

211

123

20.52

263.40

2.2

2.4

—

Acute myeloid leukaemia and myelodysplastic syndromes

148

62.70

263.36

2.9

2.4

—

Cystic kidney disease

213

135

18.61

254.65

2.2

2.5

—

Viral Sepsis

398

605

6.82

249.75

2.4

—

Implicit viral Sepsis

396

603

6.80

248.08

2.4

—

Polycystic kidney disease

192

106

22.22

246.64

2.2

2.4

—

Unspecified kidney failure

226

171

13.88

241.01

2.2

2.3

—

Glomerulonephritis

305

379

8.60

230.57

2.3

2.4

—

Implicit viral Sepsis

471

910

5.31

229.85

2.4

2.5

—

Infections, IBD-co-morbidities

407

433

6.98

224.81

2.5

—

Congenital malformations of the urinary system

255

265

10.67

223.02

2.3

2.4

—

Congenital malformations of the urinary system

259

276

10.35

222.15

2.3

2.4

—

Hypertensive diseases (excluding secondary)

800

1214

3.90

221.91

2.3

2.6

—

Other diseases of blood and blood-forming organs, wide

423

780

5.62

218.10

2.5

2.4

—

Heart failure and antihypertensive medication

426

435

6.59

215.89

2.3

2.6

—

Anaemias

581

833

4.70

209.88

2.5

2.6

—

Implicit Sepsis

913

2175

3.21

209.71

2.4

2.5

—

Acute myeloid leukaemia, helper endpoint

112

78.73

205.02

2.9

2.6

—

Acute myeloid leukaemia, including Hilmo

112

78.73

205.02

2.9

2.5

—

Acute myeloid leukaemia

112

78.73

205.02

2.9

2.6

—

Diabetic nephropathy

339

542

6.47

199.68

2.3

—

Lung transplantation

118

60.87

197.42

2.3

2.4

—

Covid-19 confirmed case

580

1493

3.98

197.35

2.4

2.5

—

Lung transplant status

117

62.15

196.85

2.3

2.4

—

Diabetic nephropathy, excluding more controls

338

436

6.69

190.84

2.3

2.4

—

ILD medications: azathioprine

314

495

6.59

190.51

2.4

2.6

—

Other and unspecified anaemias

509

1151

4.29

190.22

2.5

2.4

—

Other anaemias

511

1165

4.24

188.15

2.5

2.4

—

Any gastric operation

1050

1798

2.96

185.54

2.5

2.6

—

GASTRO-related operations

1050

1798

2.96

185.54

2.5

2.6

—

Hypertensive diseases

981

1869

3.00

184.39

2.3

2.6

—

Hypertension

980

1868

3.00

183.99

2.3

2.6

—

General symptoms and signs

1368

2721

2.55

183.94

2.4

2.5

—

Implicit Sepsis

961

2486

2.86

180.10

2.4

2.5

—

Other disorders involving the immune mechanism, not elsewhere classified

168

132

14.64

177.79

2.2

2.5

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

163

124

15.23

176.00

2.2

2.5

—

Heart failure,strict

522

875

4.27

175.80

2.3

2.4

—

IgA nephropathy (IgA glomerulonephritis)

148

17.89

173.08

2.1

2.5

—

Chronic nephritic syndrome

160

120

14.79

173.04

2.2

2.4

—

Acute peritonitis

194

196

10.61

172.15

2.3

2.5

—

Disorders of parathyroid gland

305

508

6.09

171.76

2.3

2.4

—

Hyperparathyroidism

282

440

6.52

169.77

2.2

2.3

—

Certain infectious and parasitic diseases

1172

2252

2.63

168.31

2.5

—

Condition for Implicit Sepsis (Organ dysfunction codes)

990

2595

2.72

168.10

2.4

2.5

—

Multiple myeloma, including Hilmo

127

20.08

162.61

3.5

2.2

—

Provisional assignment of new diseases of uncertain etiology

780

2729

2.90

161.48

2.5

—

Codes for special purposes

780

2734

2.90

160.94

2.5

—

Secondary and unspecified malignant neoplasm of lymph nodes

189

202

9.84

160.39

2.5

2.4

—

Anaemia in chronic diseases classified elsewhere

121

22.43

159.37

2.3

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

106

30.90

159.30

2.2

2.3

—

Chronic lymphocytic leukaemia, helper endpoint

106

30.90

159.30

2.2

2.3

—

Chronic lymphocytic leukaemia

106

30.90

159.30

2.2

2.3

—

Non-follicular lymphoma

203

243

8.76

157.70

2.6

2.3

—

Lymphoid leukaemia

166

160

11.16

152.34

2.3

2.5

—

Secondary uncertain malignant neoplasm

210

273

7.94

151.82

2.5

2.4

—

Agranulocytosis

241

368

6.85

151.16

2.6

2.4

—

Certain disorders involving the immune mechanism

347

746

4.81

150.06

2.3

2.5

—

Other heart diseases

649

1313

3.28

147.34

2.4

2.6

—

Influenza and pneumonia

1301

3725

2.24

143.06

2.5

—

Percutaneous Coronary Intervention

798

1727

2.86

142.71

2.3

2.4

—

Coronary revascularization (ANGIO or CABG)

799

1728

2.86

142.71

2.3

2.4

—

Gout, FINNGEN

336

737

4.63

140.53

2.3

—

Pneumonias (Asthma/COPD co-morbidities)

1200

3561

2.29

139.75

2.4

2.5

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1082

2739

2.42

138.82

2.4

2.5

—

1082

2739

2.42

138.82

2.4

2.5

—

Emergency coronary revascularization (for ACS)

823

1828

2.77

137.99

2.3

2.4

—

Condition for Implicit Sepsis (Organ dysfunction codes)

1012

2902

2.43

135.94

2.4

2.5

—

Pneumonia, organism unspecified

1061

3173

2.37

135.42

2.5

—

Azathioprine

314

680

4.78

134.78

2.4

2.6

—

All pneumoniae

1212

3660

2.24

133.90

2.4

2.5

—

Nephrotic syndrome

133

116

12.78

131.32

2.4

2.5

—

Other viral diseases

535

1716

3.18

129.44

2.5

—

Multiple myeloma and malignant plasma cell neoplasms

126

103

13.08

128.69

3.5

2.3

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

346

815

4.26

126.98

2.4

2.5

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1251

3123

2.20

125.75

2.5

—

Major coronary heart disease event

801

1836

2.66

124.72

2.3

2.4

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

350

851

4.13

123.32

2.4

2.5

—

Leukaemia of unspecified cell type

40.19

123.26

2.6

2.4

—

Ischemic heart diseases

804

1854

2.63

122.43

2.3

2.4

—

Cardiovascular diseases (excluding rheumatic etc)

960

2308

2.42

121.79

2.4

2.6

—

Diseases of peritoneum

207

338

6.38

121.61

2.3

2.4

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1144

3598

2.19

120.95

2.4

2.5

—

Gout

336

715

4.21

119.82

2.3

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

214

367

5.99

119.17

2.5

2.3

—

Non-Hodgkin lymphoma, all

100

17.07

119.03

2.8

2.3

—

Factors influencing health status and contact with health services

267

209

6.47

117.51

2.4

2.2

—

Persons encountering health services in other circumstances, wide

1281

3125

2.13

117.50

2.5

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

24.70

116.88

3.7

2.2

—

Multiple myeloma

24.70

116.88

3.7

2.2

—

Hypertension, essential

799

1764

2.59

115.95

2.2

2.6

—

Fibrosis and cirrhosis of liver

162

217

7.83

114.63

2.3

2.4

—

Oesophageal varices

125

121

11.13

114.48

2.3

2.4

—

Myelodysplastic syndrome, including Hilmo

21.55

113.46

2.8

2.5

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

236

465

5.24

113.19

2.4

2.3

—

Metabolic disorders

991

2682

2.28

111.78

2.4

2.5

—

Heart failure, strict

526

1218

3.08

111.45

2.3

—

Hernia of abdominal wall, postoperative

186

297

6.37

111.03

2.4

—

ILD, hospital admission 2, with pulmonary infections

148

185

8.25

110.65

2.2

2.3

—

Intestinal infectious diseases

1109

4012

2.12

110.55

2.5

—

Cirrhosis of liver, NAS

131

142

9.79

110.28

2.3

—

General examination and investigation of persons without complaint and reported diagnosis

743

1476

2.65

110.14

2.5

2.4

—

Other viral diseases

627

2379

2.67

110.07

2.5

—

Inflammatory bowel disease treatment related agents

1323

3679

2.03

109.71

2.4

2.5

—

Examination and observation for other reasons

684

1471

2.72

109.66

2.5

2.4

—

Hard cardiovascular diseases

794

1918

2.49

108.49

2.3

2.4

—

Disorders of lens

651

1498

2.74

108.47

2.3

2.4

—

Medical observation and evaluation for suspected diseases and conditions

750

1477

2.62

108.04

2.4

—

Cardiovascular diseases

935

2188

2.33

106.56

2.5

2.6

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

262

365

5.05

106.44

2.4

2.6

—

Coagulation defects, purpura and other haemorrhagic conditions

321

845

3.90

106.35

2.5

—

Heart failure and coronary heart disease

383

763

3.60

103.37

2.3

—

Other disorders of fluid, electrolyte and acid-base balance

322

824

3.78

101.68

2.3

2.4

—

Maternal care for other known or suspected fetal problems

450

901

3.24

98.81

2.7

2.5

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

181

193

6.82

98.64

2.2

2.4

—

L04AX Other immunosuppressants

663

2746

2.44

98.12

2.5

—

Genitourinary diseases

727

1448

2.54

98.12

2.4

2.5

—

Second line medication for Crohn's disease

684

2879

2.41

97.66

2.5

—

Maternal care for known or suspected fetal abnormality and damage

331

792

3.71

97.30

2.8

2.5

—

Hypertensive Renal Disease

16.09

97.13

2.1

2.3

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

106

102

10.78

96.81

2.3

2.2

—

Dependence on enabling machines and devices, not elsewhere classified

34.75

96.79

3.0

2.1

—

Rare circulating lymphoid malignancy, including Hilmo

12.51

96.66

2.6

2.5

—

Other respiratory diseases principally affecting the interstitium

215

447

4.92

96.65

2.2

2.3

—

Diseases of liver

411

1346

3.10

96.35

2.3

2.4

—

All-cause Heart Failure

490

1190

2.94

95.96

2.3

—

Other medical care

403

1170

3.13

94.03

2.4

2.5

—

Diffuse large B-cell lymphoma, including Hilmo

12.04

93.70

2.6

2.3

—

Diffuse large B-cell lymphoma

12.04

93.70

2.6

2.3

—

Diffuse large B-cell lymphoma, helper endpoint

12.04

93.70

2.6

2.3

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

628

1582

2.58

92.26

2.8

2.6

—

Diarrhoea and gastroenteritis of presumed infectious origin

1101

3655

2.00

91.89

2.5

—

Insulin, fast-acting

456

1631

2.84

91.12

2.4

2.5

—

Hepatocellular carcinoma, including Hilmo

17.80

90.83

2.3

2.2

—

Other obstetric conditions, not elsewhere classified

628

1600

2.55

90.49

2.8

2.6

—

ILD, hospital admissions 1, main diag only

176

328

5.51

89.79

2.2

2.3

—

Purpura and other haemorrhagic conditions

226

526

4.43

88.68

2.5

2.4

—

ILD, hospital admissions

184

362

5.20

88.31

2.2

2.3

—

Insulin, fast-acting or short human

458

1670

2.78

88.24

2.4

2.5

—

Interstitial lung disease

184

364

5.17

87.74

2.2

2.3

—

Interstitial lung disease endpoints

184

364

5.17

87.74

2.2

2.3

—

Other interstitial pulmonary diseases

184

364

5.17

87.74

2.2

2.3

—

Ascites

128

178

7.45

87.48

2.3

—

Acute tubulo-interstitial nephritis

630

2286

2.40

87.42

2.4

2.5

—

Diarrhoea and gastroenteritis of presumed infectious origin

832

3554

2.13

87.29

2.5

—

Fungal Sepsis

103

111

9.85

87.12

2.5

—

Thrombocytopenia, unspecified

147

239

6.43

86.92

2.5

—

Oxycodone

371

1084

3.13

86.73

2.6

2.4

—

Malignant neoplasm of liver and intrahepatic bile ducts

18.15

85.70

2.3

2.2

—

Insulin, combination of fast acting with intermediate-acting or long-acting

634

2480

2.36

85.61

2.4

—

Implicit fungal Sepsis

105

10.04

84.79

2.5

—

Presence of cardiac and vascular implants and grafts

297

608

3.66

83.88

2.4

2.2

—

All influenza

314

953

3.35

83.64

2.5

—

Certain infectious and parasitic diseases

739

1602

2.33

83.36

2.5

2.4

—

Autoimmune diseases excluding thyroid diseases

1166

3332

1.92

83.22

2.4

2.5

—

Postpartum care and examination

240

343

4.55

83.20

2.9

2.3

—

Autoimmune diseases excluding thyroid diseases, strict definition

1144

3263

1.94

83.05

2.4

2.5

—

Malignant neoplasm

825

2273

2.17

82.38

2.6

2.4

—

Malignant neoplasm, wide definition for exclusion

869

2424

2.12

82.10

2.6

2.4

—

Other special examinations and investigations of persons without complaint or reported diagnosis

689

1477

2.38

81.84

2.5

2.4

—

237

610

3.99

81.25

2.5

—

Cardiomyopathies, Primary/intrinsic

164

314

5.35

81.23

2.4

2.3

—

ILD, hospital admissions 3, with pneumonia sepsis

119

166

7.38

81.00

2.3

—

Chorioretinal inflammation

103

9.99

80.31

2.3

2.5

—

Hyperkalaemia

107

9.41

80.26

2.3

—

Cardiomyopathy (excluding other)

167

329

5.20

80.09

2.4

—

Oral corticosteroids

1110

3464

1.92

79.85

2.4

2.5

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

585

2229

2.37

79.58

2.4

—

Implicit fungal Sepsis

126

192

6.83

79.28

2.5

2.4

—

Atrial fibrillation and flutter

281

487

3.78

79.10

2.4

2.6

—

Insulin medication

634

2348

2.29

78.91

2.4

2.5

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

11.52

78.25

2.3

2.2

—

Intestinal infectious diseases

1178

3627

1.87

77.99

2.5

2.4

—

Idiopathic pulmonary fibrosis

111

152

7.54

76.86

2.2

2.3

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

481

1154

2.66

76.23

2.5

2.6

—

Abnormal findings on diagnostic imaging of lung

400

1409

2.75

75.17

2.4

2.3

—

Cardiomyopathy

202

489

4.21

75.05

2.5

2.3

—

Pregnancy examination and test

244

378

4.10

74.38

2.6

2.3

—

Drug-induced cataract

11.34

73.75

2.5

2.4

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

600

2670

2.24

72.87

2.5

2.4

—

Gout, idiopatic and unspecified

237

656

3.67

72.86

2.3

—

Supervision of high-risk pregnancy

281

479

3.60

71.37

2.8

2.4

—

Diabetic maculopathy, excluding more controls

177

406

4.49

70.84

2.4

2.5

—

Senile cataract

500

1227

2.52

70.74

2.3

2.4

—

Bronchitis

1104

3816

1.83

70.74

2.5

—

Disorders of other endocrine glands

525

2232

2.34

70.65

2.4

2.5

—

Any reimbursement code in KELA

747

1757

2.15

70.11

2.5

2.6

—

Gout, unspecified

201

510

4.01

70.06

2.4

2.3

—

Nausea and vomiting

327

1103

2.95

69.99

2.4

2.5

—

Hepatic failure, not elsewhere classified

111

8.68

69.91

2.3

2.5

—

Complications of medical and surgical care

718

3242

2.05

69.00

2.5

—

COPD/asthma/ILD related infections

1029

2739

1.89

68.80

2.4

2.5

—

COPD/asthma related infections

1029

2739

1.89

68.80

2.4

2.5

—

Acute upper respiratory infections of multiple and unspecified sites

854

3264

1.96

68.64

2.5

—

Non-ischemic cardiomyopathy

272

665

3.33

68.29

2.4

—

Viral pneumonia

186

456

4.18

68.15

2.5

2.4

—

Other bacterial intestinal infections

214

583

3.74

67.48

2.7

2.4

—

Cholangitis (primary sclerosing, PSC)

116

193

6.25

67.02

2.4

2.5

—

Human immunodeficiency virus [HIV] disease

10.53

66.86

2.1

2.4

—

Disorders of choroid and retina

694

2376

2.09

66.63

2.3

2.4

—

Other cataract

368

1014

2.77

66.57

2.3

2.4

—

Hepatocellular carcinoma

17.80

66.54

2.3

2.2

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

162

365

4.58

66.43

3.1

2.4

—

Other heart diseases, wide

984

3245

1.87

66.29

2.4

2.5

—

Neoplasms

954

2669

1.91

66.24

2.6

2.5

—

Vitreous haemorrhage

157

346

4.67

66.13

2.3

2.4

—

Type 1 diabetes

345

1273

2.75

65.12

2.4

2.5

—

Protozoal diseases

102

8.84

64.96

2.5

2.4

—

Hypertensive heart and/or renal disease

213

416

3.87

64.93

2.1

2.4

—

Presence of other functional implants

340

825

2.88

64.43

2.2

—

Pneumocystosis

12.33

63.11

2.3

—

Care involving use of rehabilitation procedures

514

2112

2.25

62.94

2.3

2.5

—

Premature rupture of membranes

348

903

2.81

62.94

2.7

2.5

—

Bacterial intestinal infections, IBD co-morbidities

212

602

3.59

62.88

2.7

2.3

—

Need for immunization against other single viral diseases

10.55

62.87

2.3

—

Diabetic retinopathy, strict definition

237

628

3.42

62.67

2.4

2.3

—

Other diseases of pleura

361

1203

2.66

62.34

2.4

2.3

—

Type 2 diabetes, wide definition

660

2034

2.09

61.96

2.3

2.4

—

Bleeding

714

2546

2.01

61.62

2.4

2.5

—

Gout, strict definition

176

446

4.01

61.53

2.4

2.3

—

Other disorders of skin and subcutaneous tissue

616

2655

2.08

60.90

2.4

—

Viral infections characterized by skin and mucous membrane lesions

473

2086

2.29

60.88

2.4

2.5

—

Endocrine, nutritional and metabolic diseases

923

2502

1.88

60.78

2.5

2.6

—

Other retinal disorders

524

1845

2.23

60.39

2.3

2.4

—

Insulin, intermediate and long-acting

508

2254

2.21

59.76

2.4

—

Persons encountering health services for examination and investigation

630

1477

2.15

59.67

2.5

2.4

—

Congenital malformations, deformations and chromosomal abnormalities

724

3590

1.94

59.48

2.3

2.5

—

Congenital malformations, deformations and chromosomal abnormalities

767

3744

1.91

59.44

2.3

2.5

—

Gingival hyperplasia

141

7.01

59.19

2.5

—

Complications of surgical and medical care, not elsewhere classified

962

3686

1.80

59.09

2.5

—

Antihypertensive medication - note that there are other indications

833

2320

1.92

58.84

2.5

2.6

—

Any death

483

1518

2.30

58.56

2.4

—

Cerebrovascular diseases (FINNGEN)

266

607

3.13

58.42

2.4

2.6

—

Oedema, not elsewhere classified

269

909

2.95

58.18

2.5

—

Autoimmune diseases

1137

3348

1.74

58.10

2.4

2.5

—

Outcome of delivery

225

394

3.60

57.87

3.0

2.4

—

Used for control exclusion in common control thyroid runs

1095

3175

1.75

57.60

2.4

2.5

—

Other pulmonary diagnosis

790

2046

1.95

57.43

2.4

2.5

—

Diabetic retinopathy, excluding more controls

300

567

3.02

57.08

2.3

—

Cardiomyopathy, other and unspecified

109

201

5.57

56.45

2.5

2.3

—

Other bacterial intestinal infections

248

829

3.04

56.37

2.7

2.5

—

Excluding asthma or asthma-COPD overlap

786

2046

1.94

56.33

2.4

2.5

—

Human immunodeficiency virus [HIV] disease resulting in other conditions

10.23

56.31

2.1

2.5

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

149

6.57

56.03

2.3

—

Dilated cardiomyopathy

146

347

4.31

55.83

2.3

2.4

—

Adjustment and management of implanted device

138

314

4.45

55.59

2.4

—

Hypo-osmolality and hyponatraemia

159

401

4.00

55.44

2.3

2.4

—

Other diseases of biliary tract

116

231

5.15

55.12

2.4

—

Gout due to impairment of renal function

19.78

54.96

2.0

2.5

—

Enterocolitis due to Clostridium difficile

135

306

4.51

54.85

2.8

2.3

—

ILD differential diagnosis

781

2049

1.92

54.73

2.4

2.5

—

COPD differential diagnosis

781

2050

1.92

54.66

2.4

2.5

—

Procreative management

373

1278

2.46

54.47

2.7

2.4

—

Drug-induced neutropenia

118

242

5.05

54.37

2.6

2.4

—

Malaise and fatigue

426

1491

2.32

54.22

2.4

2.5

—

Disorders of lipoprotein metabolism and other lipidaemias

625

1919

2.03

53.93

2.3

2.4

—

Mycoses

300

1148

2.65

52.95

2.7

2.5

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

9.65

51.81

2.5

2.6

—

Streptococcal septicaemia

109

220

5.07

51.00

2.5

2.4

—

Sub-endpoint used in defining T1D endpoints

344

1408

2.43

50.68

2.3

2.5

—

Atrial fibrillation and flutter with reimbursement

185

321

3.70

50.49

2.3

2.5

—

Type 1 diabetes, wide definition

291

1130

2.61

49.81

2.4

2.5

—

Type 1 diabetes, wide definition, subgroup 1

280

1069

2.66

49.64

2.4

2.5

—

Paroxysmal tachycardia

224

625

3.04

48.97

2.4

2.7

—

Erysipelas

378

1457

2.31

48.91

2.3

—

Symptoms and signs involving the digestive system and abdomen

972

2833

1.73

48.81

2.5

—

Renal tubulo-interstitial disorders in diseases classified elsewhere

19.82

48.80

2.3

2.5

—

Any event in cancer register

890

3008

1.75

48.70

2.6

2.4

—

Pneumonia due to other infectious organisms, not elsewhere classified

107

7.16

47.84

2.4

2.6

—

Other and unspecified disorders of white blood cells

126

6.55

47.75

2.3

2.5

—

Acquired haemolytic anaemia

8.89

47.67

2.5

—

ILD-related respiratory insufficiency

8.75

47.51

2.1

2.4

—

Heart failure and bmi 25plus

264

642

2.80

47.44

2.3

—

Viral infections characterized by skin and mucous membrane lesions

850

4245

1.72

47.02

2.4

2.5

—

Chronic tubulo-interstitial nephritis

7.93

46.96

2.2

2.6

—

Other viral diseases, not elsewhere classified

250

928

2.73

46.75

2.5

—

Explicit bacterial Sepsis

128

315

4.15

46.75

2.5

2.4

—

Haemolytic anaemias

126

6.51

46.65

2.4

—

Headache

610

2578

1.90

46.30

2.4

2.5

—

Gastrointestinal diseases

652

1706

1.93

46.24

2.5

2.6

—

Venous thromboembolism

413

1861

2.16

46.11

2.5

2.4

—

Ulcer of lower limb, not elsewhere classified

139

368

3.84

45.83

2.3

2.4

—

L01XX Other antineoplastic agents

131

6.22

45.80

2.5

2.4

—

False labour

388

1064

2.31

45.62

2.6

2.5

—

Disorders of calcium metabolism

181

5.29

45.48

2.5

2.4

—

Other disorders of white blood cells

182

5.29

45.30

2.4

2.5

—

Hypoplasia of dental enamel

12.33

45.21

3.0

2.9

—

Acute upper respiratory infections

958

3540

1.68

45.17

2.5

—

Zoster [herpes zoster]

180

570

3.21

45.02

2.3

2.4

—

Other and unspecified aplastic anaemias

15.67

44.78

2.6

2.9

—

Disorders of mineral metabolism

114

266

4.39

44.77

2.5

2.4

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

102

7.03

44.77

2.5

2.4

—

Other necrotizing vasculopathies

192

5.08

44.49

2.4

—

Tramadol

725

2479

1.81

44.48

2.3

2.5

—

Unspecified nephritic syndrome

9.02

44.29

2.2

2.5

—

Coronary atherosclerosis

439

1306

2.14

43.88

2.2

2.4

—

Personal history of other diseases and conditions

182

588

3.15

43.85

2.5

2.6

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

397

876

2.29

43.63

2.4

2.6

—

Osteopathies and chondropathies

481

2263

2.00

43.15

2.5

2.4

—

Mantle cell lymphoma, including Hilmo

15.71

42.93

2.8

2.3

—

Bacterial pneumonia (organism specified)

378

1584

2.18

42.81

2.4

—

Other abnormal products of conception

471

1538

2.06

42.40

2.8

2.5

—

Other skin changes

182

602

3.07

42.31

2.4

—

Pulmonary heart disease, diseases of pulmonary circulation

246

954

2.60

42.24

2.4

2.3

—

1026

3262

1.63

42.19

2.5

—

Diabetes mellitus in pregnancy

475

1509

2.04

41.74

2.6

—

Zoster [herpes zoster]

391

1834

2.12

41.56

2.4

—

Insulin, fast-acting (human)

207

745

2.83

41.44

2.4

2.5

—

Hyperlipidaemia, other/unspecified

264

976

2.51

41.41

2.3

—

Diabetic maculopathy

168

503

3.22

41.39

2.4

—

Nonischemic cardiomyopathy

111

269

4.21

41.39

2.4

—

Diabetic retinopathy

320

841

2.40

41.34

2.3

—

Other viral diseases, not elsewhere classified

338

1522

2.24

41.20

2.4

2.5

—

Erysipelas

481

1861

1.98

41.09

2.3

2.4

—

Alcoholic liver disease

119

308

3.95

40.67

2.3

—

Seborrhoeic keratosis

176

585

3.04

40.53

2.3

—

Symptoms and signs involving the skin and subcutaneous tissue

645

3583

1.77

40.49

2.5

—

Hodgkin lymphoma, hilmo

124

6.14

40.49

2.3

2.5

—

IBD (strict) with PSC

12.32

40.46

2.5

2.7

—

Special screening examination for infectious and parasitic diseases

338

1107

2.28

40.39

2.8

2.5

—

Osteoporosis

187

598

2.95

40.22

2.4

2.3

—

Other maternal disorders predominantly related to pregnancy

589

2007

1.86

39.39

2.7

2.5

—

Congenital malformations of gallbladder, bile ducts and liver

12.10

38.92

2.4

2.3

—

Antenatal screening

242

508

2.71

38.58

2.7

2.4

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

452

1320

2.03

38.48

2.7

2.5

—

Colitis, primary sclerosing

9.32

38.45

2.5

2.6

—

Bacterial pneumoniae

323

1291

2.22

38.20

2.4

2.5

—

Periodontitis

811

3272

1.67

38.18

2.4

2.5

—

Gestational diabetes (for exclusion)

536

2006

1.88

38.06

2.7

2.6

—

COPD-related respiratory insufficiency

107

269

4.04

38.01

2.1

2.3

—

Infections of the skin and subcutaneous tissue

587

3277

1.79

37.93

2.4

2.5

—

Chronic periodontitis, including avohilmo

808

3273

1.66

37.80

2.4

2.5

—

Other respiratory disorders and diseases

164

547

3.03

37.57

2.4

—

Other diseases of the respiratory system

164

547

3.03

37.57

2.4

—

Charcot foot

9.94

37.49

2.5

—

Respiratory insufficiency

118

5.83

37.38

2.4

—

Mature T/NK-cell lymphomas, hilmo

12.41

37.36

2.9

2.4

—

Caries of enamel

871

3913

1.62

36.78

2.5

—

Follicular lymphoma, hilmo

101

6.35

36.67

2.2

2.4

—

Spontaneous abortion

509

1832

1.89

36.65

2.7

2.5

—

Molar incisor enamel hypoplasia, with caries

13.94

36.12

3.1

3.0

—

Diseases of arteries, arterioles and capillaries

470

1826

1.91

35.92

2.3

2.4

—

Iridocyclitis

233

954

2.47

35.91

2.2

2.5

—

Bacterial pneumonia, not elsewhere classified

303

1211

2.22

35.78

2.4

—

Other infectious diseases

101

256

4.04

35.62

2.4

2.5

—

Statin medication

636

2038

1.77

35.50

2.3

2.6

—

Other acute lower respiratory infections

484

2499

1.86

35.43

2.5

—

Valvular heart disease excluding rheumatic fever

340

1152

2.15

35.42

2.4

—

Pure hypercholesterolaemia

492

1708

1.89

35.40

2.2

2.4

—

Diseases of oesophagus, stomach and duodenum

946

3595

1.58

35.37

2.4

2.5

—

Other pleural conditions

223

4.24

35.24

2.3

—

Diagnoses used for exclusion with ILD

210

828

2.56

35.01

2.4

—

Single delivery by caesarean section

238

536

2.59

34.99

2.8

2.4

—

Nutritional anaemias

379

1834

2.01

34.93

2.4

2.5

—

Abdominal and pelvic pain

903

2833

1.61

34.91

2.4

2.5

—

Other infectious diseases

114

320

3.64

34.73

2.5

2.4

—

Other and unspecified polyneuropathies, also in other diseases

165

578

2.89

34.71

2.4

2.3

—

Chronic periodontitis, complicated

420

2180

1.92

34.39

2.3

2.4

—

Maternal care for known or suspected malpresentation of fetus

260

803

2.38

34.31

2.7

2.5

—

Diseases of the eye and adnexa

868

2704

1.62

34.18

2.4

2.5

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

468

2542

1.85

34.13

2.3

2.5

—

Amiodarone users

246

4.02

34.13

2.3

—

Missing teeth due to accident, extraction or parodontitis

430

2138

1.91

34.10

2.3

2.4

—

Supervision of normal pregnancy

224

493

2.63

33.98

2.7

2.4

—

Iron deficiency anaemia

339

1635

2.06

33.69

2.4

2.5

—

Sarcoidosis

144

476

3.08

33.69

2.4

—

Postpartum haemorrhage

338

1380

2.09

33.66

2.8

2.5

—

Amputation

231

4.09

33.61

2.3

—

Neurotic, stress-related and somatoform disorders

870

3869

1.58

33.58

2.5

—

Continuous positive airway pressure

159

458

2.95

33.49

2.4

—

Diseases of the skin and subcutaneous tissue

924

2945

1.58

33.29

2.4

2.5

—

Anxiety disorders

873

3882

1.58

33.12

2.5

—

Polyarthropathies

661

2564

1.69

33.05

2.3

2.5

—

L01XE Protein kinase inhibitors

153

4.91

32.89

2.4

—

Non-rheumatic valve diseases

329

1136

2.10

32.65

2.3

2.4

—

Polyneuropathies and other disorders of the peripheral nervous system

180

683

2.67

32.52

2.3

—

Other reaction to severe stress, and adjustment disorders

439

2391

1.85

32.06

2.5

—

Maternal care for known or suspected abnormality of pelvic organs

301

951

2.18

32.05

2.9

2.5

—

Gingivitis and periodontal diseases

855

2782

1.59

32.03

2.4

—

Other diseases of liver

176

670

2.66

31.65

2.3

2.4

—

Systemic connective tissue disorders

287

1357

2.13

31.45

2.3

2.5

—

All influenza (not pneumonia)

161

588

2.78

31.40

2.6

2.4

—

Other diseases of pericardium

107

5.67

31.25

2.3

2.4

—

Dyspnoea

750

3473

1.60

31.06

2.3

2.5

—

Diseases of the digestive system

359

1839

1.96

31.04

2.4

—

Ulcerative colitis (strict) with PSC

11.83

30.97

2.4

2.7

—

Pacemaker

193

740

2.52

30.94

2.4

2.3

—

Viral pneumonia (known virus, not influenza)

6.31

30.90

2.8

2.4

—

Peripheral artery operations in Hilmo

101

285

3.59

30.43

2.3

—

Disorders of sclera, cornea, iris and ciliary body

489

2794

1.76

30.36

2.3

2.5

—

Heart failure and hypertrophic cardiomyopathy

9.72

30.29

2.4

2.3

—

Colitis, primary sclerosing, strict definition

9.59

30.27

2.5

2.6

—

Diabetes, varying definitions

910

3482

1.54

30.27

2.4

2.5

—

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

6.86

30.21

2.4

2.1

—

DVT of lower extremities and pulmonary embolism

290

1391

2.09

30.21

2.5

2.4

—

Acute bronchitis

349

1763

1.96

30.05

2.4

2.5

—

Diabetes mellitus

914

3509

1.53

29.53

2.4

2.5

—

Isolated proteinuria

125

5.20

29.42

2.4

2.5

—

Pulmonary embolism

207

880

2.37

29.36

2.4

2.3

—

Pulmonary heart disease

207

886

2.36

28.92

2.4

2.3

—

ILD medications: pirfenidone

34.24

28.78

2.2

2.0

—

Anxiety disorders, excluding more controls

786

3285

1.56

28.70

2.5

—

Habitual aborter

149

4.78

28.46

3.0

2.7

—

Dermatitis and eczema

983

4112

1.49

28.26

2.5

—

Aspergillosis

11.77

28.20

2.9

2.5

—

Symptoms and signs involving the circulatory and respiratory systems

982

3293

1.50

28.13

2.5

—

Isolated proteinuria with specified morphological lesion

9.66

28.09

2.2

2.6

—

Pleural effusion

111

351

3.20

28.00

2.2

2.4

—

Other diseases of the digestive system

234

1070

2.20

27.96

2.4

—

Melanocytic naevi

304

1536

2.00

27.95

2.6

2.5

—

Ischaemic heart disease, wide definition

510

1826

1.74

27.84

2.2

2.4

—

Secondary right heart disease

5.82

27.82

2.4

—

Other problems related to primary support group, including family circumstances

182

730

2.48

27.79

2.6

—

Perineal laceration during delivery

271

1092

2.11

27.64

2.8

2.6

—

Myelodysplastic syndrome

28.92

27.61

2.8

2.7

—

Abnormal findings on examination of urine, without diagnosis

173

4.30

27.47

2.5

—

Phlebitis and thrombophlebitis (not including DVT)

192

815

2.38

27.44

2.4

2.5

—

Autoimmune diseases related-to ILD

740

4098

1.55

27.38

2.4

2.5

—

Diseases of oral cavity, salivary glands and jaws

427

1195

1.85

27.24

2.4

—

Retinal detachments and breaks

232

1069

2.19

27.21

2.4

2.3

—

Opioids

931

3231

1.50

27.14

2.3

2.5

—

Gastroduodenal ulcer

169

678

2.50

27.09

2.3

—

Diseases of the respiratory system

573

1706

1.69

27.03

2.5

—

GI-bleeding

230

1059

2.19

27.02

2.4

—

Asthma, excluding more controls

607

1923

1.65

26.60

2.4

2.5

—

Other metabolic disorders

142

531

2.71

26.57

2.6

—

Follow-up examination after treatment for conditions other than malignant neoplasms

365

1285

1.89

26.57

2.5

—

Other necrotizing vasculopathies (FG)

152

4.43

26.49

2.3

2.5

—

Early onset COPD, excluding more controls

139

514

2.73

26.44

2.2

2.4

—

Peripheral artery disease

253

955

2.12

26.38

2.3

—

Single delivery by forceps and vacuum extractor

189

464

2.49

26.30

2.6

2.5

—

Unspecified human immunodeficiency virus [HIV] disease

9.20

26.16

2.1

2.6

—

Anterior Iridocyclitis

196

858

2.31

26.16

2.3

2.5

—

Dermatitis

512

3076

1.67

26.13

2.4

2.5

—

Osteonecrosis

188

4.03

26.13

2.7

2.3

—

Arthropathies in other diseases classified elsewhere

115

5.02

25.92

2.4

2.6

—

Other diseases of urinary system

887

3344

1.50

25.84

2.5

—

Disorders of vitreous body and globe

332

1699

1.89

25.82

2.3

2.4

—

Hypocalcemia

6.03

25.64

2.2

2.5

—

Myocarditis

112

5.01

25.60

2.4

2.6

—

Other autoimmune haemolytic anaemias

11.00

25.59

2.5

2.6

—

Other CVD (FINNGEN)

175

3.76

25.32

2.2

2.6

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

729

2848

1.55

25.21

2.3

2.5

—

Hypertensive Heart Disease

134

380

2.78

25.09

2.2

2.4

—

Myeloproliferative diseases

221

3.68

25.05

2.4

—

Cardiac arrhythmias

545

2158

1.65

24.85

2.5

—

Viral warts

132

494

2.72

24.78

2.4

2.5

—

Amputation of toe

183

3.95

24.56

2.3

—

Localized swelling, mass and lump of skin and subcutaneous tissue

267

1351

1.99

24.49

2.5

—

Hypercalcemia

102

5.13

24.31

2.7

2.5

—

Delivery, wide proxy

242

597

2.17

24.15

2.7

2.3

—

Complications of procedures, not elsewhere classified

643

3433

1.56

24.12

2.4

2.5

—

Acute and subacute iridocyclitis

185

819

2.29

24.09

2.2

2.5

—

Reimbursement for rheumatic diseases

452

2694

1.68

23.80

2.3

2.5

—

Poor fetal growth

219

1048

2.13

23.70

2.5

2.7

—

Parasetamol

744

2475

1.53

23.52

2.4

2.5

—

Chronic hepatitis, not elsewhere classified

121

4.70

23.51

2.3

2.5

—

Type 2 diabetes

798

3129

1.50

23.43

2.3

2.5

—

Other pulmonary heart/vessel disease

106

4.92

23.25

2.4

—

Disorders of tooth development and eruption

193

703

2.25

23.20

2.6

2.5

—

Disorders of vitreous body

315

1656

1.85

23.01

2.3

2.4

—

Other complications of labour and delivery, not elsewhere classified

209

908

2.15

22.90

2.8

2.6

—

Other and unspecified iron deficiency

256

1308

1.97

22.81

2.4

2.5

—

Candidiasis

150

623

2.44

22.68

2.7

2.5

—

Asthma

610

2028

1.58

22.64

2.4

2.5

—

Asthma (only as main-diagnosis), excluding more controls

543

1923

1.62

22.63

2.4

2.5

—

Chronic myeloproliferative disease

8.76

22.48

2.8

2.3

—

STROKE

349

1319

1.81

22.32

2.4

2.5

—

Other and unspecified dermatitis

427

2564

1.68

22.29

2.4

2.5

—

Secondary thrombocytopenia

8.98

22.11

2.3

2.6

—

Dental operations

426

1270

1.73

22.10

2.4

—

Cellulitis

205

981

2.11

22.02

2.3

2.5

—

Abnormalities of breathing

825

3281

1.47

21.99

2.3

2.5

—

Viral pneumonia (unknown virus, not influenza)

304

3.09

21.78

2.3

2.4

—

Diabetes, insulin treatment (Kela reimbursement)

757

3090

1.49

21.68

2.3

2.5

—

Gastric ulcer

118

446

2.67

21.64

2.3

—

Osteomyelitis

205

3.58

21.64

2.4

—

Complications of labour and delivery

531

1839

1.61

21.61

2.7

2.5

—

Diseases of spleen

6.26

21.43

2.4

2.5

—

Symptoms and signs involving the urinary system

553

2693

1.57

21.40

2.3

2.5

—

Mantle cell lymphoma

19.62

21.36

2.9

2.4

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

337

1520

1.78

21.34

2.3

2.4

—

Hepatomegaly and splenomegaly, not elsewhere classified

9.02

21.27

2.3

2.2

—

Haemorrhage in early pregnancy

284

1497

1.86

21.27

2.7

2.6

—

Pre-eclampsia or poor fetal growth

359

2080

1.74

21.26

2.5

2.6

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

720

3105

1.49

21.22

2.4

—

Other and unspecified coagulation defects

213

3.52

21.21

2.5

—

Hydronephrosis

308

3.02

21.20

2.3

2.4

—

Maternal care for other conditions predominantly related to pregnancy

264

1373

1.91

21.18

2.6

—

Pregnancy, childbirth and the puerperium

200

473

2.22

21.18

2.7

2.3

—

Other diseases of hard tissues of teeth

399

1194

1.74

21.01

2.4

—

Other gastritis (incl. Duodenitis)

161

714

2.27

20.91

2.3

—

Asthma, unspecified (mode), excluding more controls

372

1618

1.73

20.87

2.4

2.5

—

Unspecified jaundice

116

4.48

20.85

2.4

2.5

—

Viral and other specified intestinal infections

327

1796

1.77

20.73

2.5

—

Chronic apical periodontitis

963

3908

1.41

20.61

2.3

2.5

—

Cystitis

721

2901

1.48

20.50

2.5

—

ILD medications: nintedanib

40.67

20.39

2.4

2.0

—

Other disorders of urethra and urinary system

558

2607

1.55

20.30

2.5

—

Other coagulation defects

301

3.01

20.25

2.5

2.4

—

Abnormal findings on examination of blood, without diagnosis

334

1764

1.75

20.19

2.4

—

Persons encountering health services for specific procedures, not carried out

329

2.90

20.09

2.4

2.5

—

Haemorrhage, not elsewhere classified

5.45

20.01

2.3

2.5

—

Pain, not elsewhere classified

222

1133

1.97

19.97

2.3

2.6

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

121

484

2.53

19.89

2.7

2.6

—

Other congenital malformations of the digestive system

206

3.47

19.87

2.5

—

Persons encountering health services in other circumstances

340

1974

1.72

19.81

2.5

—

Erectile dysfunction

213

3.39

19.70

2.5

2.3

—

Asthma (only as main-diagnosis)

545

2028

1.56

19.59

2.4

2.5

—

Iron deficiency anaemia secondary to blood loss (chronic)

120

482

2.51

19.52

2.4

—

Idiopathic gout

235

3.24

19.39

2.1

2.3

—

Hypothyroidism (congenital or acquired)

295

910

1.84

19.33

2.5

2.6

—

Other inflammatory liver diseases

236

3.24

19.31

2.2

2.4

—

Any operation in hilmo

9.45

19.28

2.6

2.7

—

Osteonecrosis due to drugs

7.55

19.26

2.7

2.3

—

Solid cancers, helper endpoint

572

2209

1.53

19.12

2.4

—

Cardiac arrest

4.46

19.10

2.5

2.6

—

Viral and other specified intestinal infections

260

1387

1.85

19.02

2.5

—

Neovascular glaucoma

113

4.35

18.84

2.3

2.5

—

Other and unspecified diseases of blood and blood-forming organs

5.45

18.84

2.2

2.4

—

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

138

3.93

18.81

2.3

2.2

—

Other specified and unspecified retinal disorders

101

4.57

18.78

2.3

2.5

—

Haemorrhage from respiratory passages

226

1063

1.93

18.73

2.3

2.4

—

Cutaneous abscess, furuncle and carbuncle

248

1343

1.86

18.73

2.5

—

Diabetes medication

857

3617

1.41

18.68

2.4

2.5

—

Asthma (mode)

582

2049

1.53

18.64

2.4

2.5

—

Chronic gastritis

159

736

2.17

18.63

2.3

2.4

—

Benign neoplasms

911

3608

1.40

18.55

2.5

—

Single spontaneous delivery

275

788

1.86

18.26

2.6

2.4

—

Other or ill-defined heart diseases

170

3.59

18.20

2.3

2.4

—

Diabetic neuropathy

112

449

2.52

18.18

2.4

2.3

—

Background retinopathy and retinal vascular changes

5.89

18.18

2.2

2.3

—

Symptoms and signs concerning food and fluid intake

292

2.90

18.11

2.2

2.5

—

Glaucoma secondary to other eye disorders

117

4.20

18.02

2.3

2.5

—

Gastro-oesophageal reflux disease

483

2702

1.55

18.02

2.5

—

Non-invasive ventilation

195

876

2.00

17.98

2.4

2.6

—

Asthma, unspecified (mode)

373

1706

1.65

17.90

2.4

2.5

—

Pericarditis

4.62

17.81

2.3

—

Female infertility

367

1338

1.68

17.77

2.7

2.6

—

Acute nephritic syndrome

5.19

17.77

2.2

2.5

—

Labour and delivery complicated by fetal stress [distress]

311

1174

1.75

17.76

2.7

2.6

—

Amputation of ankle bones

6.31

17.76

2.1

2.3

—

Acute lymphadenitis

297

2.89

17.74

2.4

2.5

—

Atherosclerosis, excluding cerebral and coronary sclerosis

206

835

1.96

17.63

2.3

—

Postpartum hemorraghe, all women as controls

338

2005

1.68

17.63

2.8

2.6

—

Other disorders of amniotic fluid and membranes

164

768

2.11

17.61

2.7

2.5

—

Other congenital malformations of the digestive system

248

3.08

17.60

2.5

—

Chronic iridocyclitis

189

3.41

17.58

2.2

2.6

—

Benign neoplasm: Colon

304

1697

1.72

17.51

2.3

—

Other embolism and thrombosis

103

406

2.56

17.49

2.3

2.4

—

Candidiasis

266

1504

1.78

17.47

2.6

2.5

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

114

472

2.44

17.44

2.4

—

Unspecified haematuria

268

1249

1.79

17.33

2.3

2.4

—

Acute lymphocytic leukaemia

7.52

17.30

2.6

—

Acute lymphocytic leukaemia, including Hilmo

7.52

17.30

2.6

—

Acute lymphocytic leukaemia, helper endpoint

7.52

17.30

2.6

—

Noninfective enteritis and colitis

392

2457

1.60

17.30

2.5

—

Arterial embolism and thrombosis

125

3.98

17.25

2.2

2.4

—

Disorders of oesophagus in diseases classified elsewhere

6.56

17.20

2.4

2.5

—

Presence of other devices

112

462

2.43

17.06

2.4

2.3

—

Volume depletion

238

3.06

17.04

2.5

2.4

—

Hypertrophic cardiomyopathy

127

3.95

16.97

2.3

2.4

—

Delivery

271

791

1.82

16.82

2.6

2.4

—

Other disorders of lacrimal gland

256

1448

1.78

16.78

2.4

2.5

—

All anxiety disorders

607

3303

1.46

16.78

2.5

—

Disorders of lacrimal system

299

1768

1.70

16.55

2.4

2.5

—

Unspecified acute lower respiratory infection

140

648

2.18

16.54

2.7

2.4

—

Actinic keratosis

163

736

2.06

16.48

2.3

2.2

—

Hypothyroidism, levothyroxine purchases

283

908

1.77

16.47

2.5

2.6

—

Hypothyroidism and >3 levothyroxin purchases

283

908

1.77

16.47

2.5

2.6

—

Benign neoplasm of colon, rectum, anus and anal canal

359

1929

1.62

16.42

2.3

2.4

—

Pain (limb, back, neck, head abdominally)

623

2133

1.47

16.41

2.5

—

Pregnancy with abortive outcome

563

1972

1.50

16.39

2.6

2.5

—

Retinal vascular occlusion

249

2.96

16.36

2.3

—

Disorders of gallbladder, biliary tract and pancreas

732

3280

1.41

16.36

2.4

2.5

—

Covid-19 suspected case

228

1258

1.83

16.31

2.6

2.5

—

Complications of cardiac and vascular prosthetic devices, implants and grafts

5.98

16.28

2.2

2.4

—

Cystic disease of liver

16.05

16.27

2.2

2.3

—

Viral warts

215

1166

1.86

16.27

2.4

2.6

—

Budesonide

134

614

2.21

16.25

2.6

—

Immunodeficiency with predominantly antibody defects

101

4.30

16.15

2.5

—

Retinal vascular disorders

251

2.94

16.13

2.3

—

Rare circulating lymphoid malignancy

36.72

16.06

2.5

3.0

—

Persons encountering health services in circumstances related to reproduction

448

1959

1.55

16.04

2.5

2.4

—

Skin changes due to chronic exposure to nonionizing radiation

167

768

2.01

15.90

2.3

—

Malignant immunoproliferative diseases

7.62

15.86

2.6

2.4

—

Asthma, hospital admissions 3, pneumonia

249

1418

1.76

15.84

2.4

2.5

—

Asthma-related pneumonia or sepsis

249

1418

1.76

15.84

2.4

2.5

—

Idiopathic thrombocytopenic purpura

116

4.00

15.76

2.4

—

Asthma-related pneumonia

248

1413

1.76

15.75

2.4

2.5

—

Other diseases of blood and blood-forming organs

213

3.10

15.70

2.2

2.4

—

Anxiety (asthma-related co-morbidities)

596

3204

1.45

15.69

2.5

—

Syncope and collapse

272

1360

1.72

15.54

2.3

2.5

—

Melanocytic naevi, other sites/unspecified

371

2.55

15.54

2.4

—

Other diseases of intestines

927

3919

1.35

15.49

2.4

2.5

—

COPD (mode)

144

533

2.13

15.48

2.2

2.4

—

Other CVD

111

480

2.33

15.42

2.2

2.4

—

Retinal haemorrhage

5.61

15.32

2.6

2.4

—

Molar incisor enamel hypoplasia

204

3.12

15.20

2.9

2.6

—

SLE (Finngen)

110

4.00

15.19

2.1

2.6

—

Primary biliary cholangitis (PBC)

5.76

15.16

2.6

2.7

—

Visual disturbances and blindness

379

2437

1.56

15.11

2.4

2.5

—

Herpesviral [herpes simplex] infections

114

505

2.29

15.06

2.4

—

Acute sinusitis

469

2923

1.49

14.96

2.5

—

Immunodeficiencies

185

3.20

14.72

2.4

2.5

—

Diseases of pulp and periapical tissues and dental caries

475

1612

1.51

14.70

2.4

—

Hernia of abdominal wall

319

1985

1.62

14.69

2.4

—

Other diseases of arteries and capillaries

288

2.71

14.63

2.4

—

Carcinoma in situ of skin

165

3.31

14.62

2.5

2.3

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

328

2037

1.60

14.55

2.6

—

Other noninfective gastroenteritis and colitis

198

1085

1.84

14.48

2.4

2.5

—

Diverticular disease of intestine

411

1709

1.54

14.40

2.3

2.4

—

Hypoplasia of dental enamel , including avohilmo

192

3.13

14.39

2.9

2.6

—

AV-block

348

2.43

14.37

2.4

2.3

—

Female infertility, cervical, vaginal, other or unspecified origin

324

1302

1.63

14.37

2.7

2.6

—

Prolonged pregnancy

177

817

1.92

14.35

2.6

2.5

—

Cardiodefibrillation

190

1030

1.85

14.28

2.4

2.3

—

Disorders of skin appendages

434

2914

1.50

14.15

2.4

2.5

—

Other arterial embolism and thrombosis

4.74

14.06

2.3

2.4

—

Dysphagia

151

766

1.98

14.00

2.4

—

Melanocytic naevi of trunk

125

594

2.13

13.93

2.5

—

Cardiomyopathy, Hypertrophic obstructive

5.70

13.92

2.2

2.6

—

Other specified disorders of kidney and ureter

100

3.99

13.76

2.3

2.5

—

Failed induction of labour

101

444

2.33

13.75

2.9

2.7

—

Antepartum haemorrhage, not elsewhere classified

106

475

2.27

13.71

2.8

2.5

—

Myocardial infarction

244

999

1.72

13.68

2.3

2.4

—

Other disorders of conjunctiva

101

444

2.30

13.61

2.3

2.4

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

102

451

2.29

13.60

2.6

2.4

—

Disease of hard tissues of teeth, NOS

357

1183

1.58

13.59

2.4

—

Endocarditis

4.17

13.52

2.2

2.4

—

Polyhydramnios

245

2.79

13.41

2.4

2.5

—

Medullary cystic kidney disease, nephronophthisis

42.59

13.37

2.3

2.6

—

Visual impairment including blindness (binocular or monocular)

201

2.98

13.37

2.2

2.5

—

Umbilical hernia

218

1261

1.74

13.36

2.4

2.5

—

Other and unspecified iridocyclitis

186

3.07

13.32

2.2

2.5

—

Papilloedema, unspecified

103

3.91

13.28

2.3

2.6

—

Cough

288

1699

1.61

13.10

2.5

—

175

870

1.85

13.09

2.3

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

204

2.93

13.02

2.7

2.4

—

Peripheral arterial reconstruction

359

2.41

13.02

2.3

2.2

—

Medical treatment for female infertility

265

1619

1.64

12.99

2.6

—

Cerebral cysts

272

2.66

12.97

2.4

2.5

—

Chronic myeloid leukaemia, including Hilmo

12.98

12.80

2.2

—

Hypokalaemia

333

2.45

12.71

2.5

2.4

—

Systemic lupus erythematosus

125

3.52

12.69

2.1

2.6

—

Squamous cell neoplasms and carcinomas of the skin

4.29

12.63

2.2

2.1

—

Marginal zone B-cell lymphoma, including Hilmo

9.63

12.59

2.2

—

Aortic valve malfunction, age under 60 years

403

2.31

12.58

2.3

2.4

—

Myeloproliferative diseases (CML excluded)

203

2.89

12.54

2.5

2.4

—

Hypotension

384

2.33

12.53

2.2

2.3

—

Inflammatory diseases of the central nervous system

349

2.41

12.46

2.4

—

Complications predominantly related to the puerperium

280

1763

1.60

12.45

2.7

2.6

—

Fluid overload

30.66

12.43

2.3

2.8

—

Sequelae of external causes of morbidity and mortality

177

985

1.81

12.42

2.4

—

Chronic ulcer of skin, not elsewhere classified

167

3.09

12.39

2.4

—

Abnormal findings on diagnostic imaging of other body structures

450

2.22

12.36

2.4

—

Tuberculosis of other organs, strict

5.45

12.34

2.3

2.4

—

Vocal cord dysfunction

102

418

2.21

12.31

2.3

2.6

—

Other symptoms and signs involving the digestive system and abdomen

118

579

2.05

12.09

2.3

2.4

—

Other mycoses, not elsewhere classified/unspecified

18.76

12.07

2.8

3.0

—

Conjunctivitis (acute, non atopic)

249

1531

1.63

12.00

2.5

—

Other and unspecified local infections of skin and subcutaneous tissue

393

2.29

11.96

2.5

2.4

—

Encephalopathy

9.43

11.94

2.4

2.3

—

Long labour

247

1298

1.64

11.90

2.6

2.5

—

Other congenital malformations of urinary system

10.26

11.87

3.0

2.4

—

conjunctival haemorrhage

215

2.78

11.87

2.4

—

Osteoporosis with pathological fracture (FG)

116

3.48

11.81

2.4

—

Dental caries, including avohilmo

516

1860

1.42

11.80

2.4

—

Abnormal findings on antenatal screening of mother

136

712

1.94

11.74

2.7

—

Convulsions, not elsewhere classified

177

990

1.78

11.70

2.3

2.6

—

Other local infections of skin and subcutaneous tissue

416

2.24

11.69

2.5

—

Family history of certain disabilities and chronic diseases leading to disablement

240

2.67

11.69

3.2

2.6

—

Disorder of lipoprotein metabolism, unspecified

292

2.48

11.66

2.3

2.4

—

Abnormal results of function studies

354

2.35

11.63

2.4

—

SLE, strict definition

123

3.41

11.56

2.1

2.6

—

SLE, ICD10

123

3.41

11.56

2.1

2.6

—

Wegener granulomatosis

4.98

11.53

2.2

2.5

—

Depression

797

4132

1.31

11.43

2.4

2.5

—

Other soft tissue disorders, not elsewhere classified

797

3564

1.31

11.39

2.4

2.5

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

207

824

1.71

11.30

2.3

2.2

—

Retinal detachment with retinal break

352

2.32

11.29

2.4

2.3

—

Other diseases of stomach and duodenum

161

3.02

11.23

2.3

—

Encephalitis

121

3.39

11.16

2.4

2.5

—

Other renal tubulo-interstitial diseases

4.24

11.13

2.3

2.7

—

Tuberculosis of other organs

5.36

11.11

2.0

2.4

—

Postpartum hemorraghe, parous women as controls

338

1932

1.50

11.06

2.8

2.6

—

Syphilis

3.75

11.03

2.3

—

Syphilis

3.75

11.03

2.3

—

Thrombotic microangiopathy

11.43

11.02

2.5

2.6

—

Osteopathy in diseases classified elsewhere

11.30

10.98

2.9

2.4

—

Hypersplenism

19.57

10.98

2.3

2.4

—

Neurological diseases, wide definition

343

1137

1.52

10.95

2.5

2.6

—

Urolithiasis

206

1242

1.67

10.92

2.4

—

Hypersensitivity angiitis

14.12

10.91

2.3

2.1

—

Acute posthaemorrhagic anaemia

4.15

10.90

2.2

2.4

—

Amputation of foot

4.38

10.82

2.1

2.4

—

Infections with a predominantly sexual mode of transmission

329

2213

1.49

10.81

2.5

2.6

—

DVT of lower extremities

113

570

2.00

10.78

2.5

2.4

—

Mycoses

674

4442

1.32

10.78

2.6

2.5

—

Diseases of middle ear and mastoid

547

3285

1.37

10.76

2.5

—

Other encephalitis

114

3.42

10.76

2.4

2.5

—

Hypertension, portal

18.30

10.70

2.0

2.3

—

Persons with potential health hazards related to communicable diseases

410

2860

1.43

10.69

2.3

2.6

—

Functional dyspepsia

187

1106

1.70

10.68

2.5

—

Preterm labour and delivery

196

1175

1.68

10.65

2.5

—

Other disorders of optic [2nd] nerve and visual pathways

258

2.52

10.60

2.2

2.5

—

Conduction disorders

159

722

1.79

10.60

2.4

—

Depression medications

293

946

1.56

10.60

2.5

2.6

—

6-mercaptopurine

162

2.96

10.56

2.4

2.5

—

Renal agenesis and other reduction defects of kidney

11.52

10.53

1.9

3.4

—

Diaphragmatic hernia

192

1148

1.68

10.51

2.4

2.3

—

Chronic myeloid leukaemia [CML], BCR/ABL-positive

8.64

10.49

2.2

2.4

—

Other and unspecified vascular occlusions

184

2.79

10.47

2.2

2.3

—

Acute pancreatitis

125

662

1.90

10.36

2.4

—

Sequelae with surgical and medical care as external cause

132

712

1.87

10.35

2.5

2.4

—

Malignant neoplasm of digestive organs

160

713

1.78

10.34

2.4

2.2

—

Major coronary heart disease event excluding revascularizations

285

1235

1.54

10.31

2.2

2.4

—

Other leukaemias of specified cell type

19.61

10.28

2.8

2.1

—

Unspecified contracted kidney

12.19

10.28

2.1

2.6

—

Carcinoma in situ of skin of other and unspecified parts of face

127

3.18

10.27

2.3

2.2

—

Diseases of pulp and periapical tissues, including avohilmo

839

3379

1.29

10.22

2.4

2.5

—

Hernia

660

3352

1.32

10.19

2.4

2.5

—

Renal agenesis and other reduction defects of kidney

11.63

10.04

1.9

3.5

—

Polycythaemia vera

4.51

10.04

2.4

2.2

—

Dermatitis due to substances taken internally

218

2.61

9.99

2.5

—

Other disorders of glucose regulation and pancreatic internal secretion

359

2.23

9.99

2.3

2.4

—

Tubulo-interstitial nephritis, not specified as acute or chronic

201

2.67

9.93

2.2

2.4

—

Hypoplasia of dental enamel, prenatal

21.55

9.89

3.1

2.5

—

Glaucoma

276

1564

1.52

9.87

2.3

—

Asthma-related infections

436

3079

1.39

9.84

2.4

2.5

—

Asthma, hospital admission 2, infections

436

3079

1.39

9.84

2.4

2.5

—

Degenerative macular diseases

237

2.51

9.82

2.1

2.3

—

Dermatophytosis

454

2.07

9.78

2.4

—

Elevated blood glucose level

313

2.29

9.67

2.3

2.4

—

Other diseases of intestine

436

2.08

9.65

2.4

—

Other and unspecified acquired haemolytic anaemias

9.51

9.65

2.2

2.5

—

Injury, poisoning and certain other consequences of external causes

491

1784

1.38

9.64

2.4

2.6

—

Visual disturbances

334

2309

1.45

9.63

2.4

2.5

—

Diseases of tongue

160

2.84

9.54

2.5

2.4

—

Use of antiglaucoma preparations and miotics

161

2.82

9.42

2.3

2.4

—

Acute pancreatitis (for exclusion)

125

684

1.84

9.40

2.4

2.3

—

Late syphilis

5.04

9.39

2.5

2.4

—

Cerebrovascular diseases

398

1988

1.41

9.33

2.3

2.4

—

Myocardial infarction, strict

212

942

1.61

9.33

2.3

2.4

—

Mood disorders, excluding more controls

726

3362

1.29

9.31

2.4

2.5

—

Other diseases of pancreas

226

2.50

9.28

2.4

—

Fitting and adjustment of other devices

134

676

1.79

9.23

2.3

—

Other noninfective disorders of lymphatic vessels and lymph nodes

105

3.29

9.20

2.3

2.6

—

Fibrosis of liver

9.60

9.19

2.3

2.4

—

Calculus of kidney and ureter

189

1172

1.62

9.07

2.4

—

Corns and callosities

217

2.52

9.05

2.4

—

Noninfectious colitis NAS

116

629

1.86

9.03

2.3

2.4

—

Acquired absence of organs, not elsewhere classified

7.70

9.02

2.0

2.2

—

Degeneration of macula and posterior pole

186

907

1.64

9.00

2.2

2.3

—

Mood [affective] disorders

813

4173

1.27

8.97

2.4

2.5

—

Toxoplasmosis

10.19

8.96

3.1

—

Mood disorders

814

4172

1.27

8.96

2.4

2.5

—

Congenital malformation of biliary tract

13.39

8.93

2.8

2.4

—

Benign neoplasm: Transverse colon

292

2.28

8.93

2.2

2.3

—

Valvular operations

350

2.16

8.89

2.5

2.4

—

Malignant melanoma, including Hilmo

383

2.10

8.88

2.3

—

Inflammatory diseases of female pelvic organs

498

2729

1.35

8.85

2.6

2.5

—

Malignant neoplasm of skin

210

907

1.59

8.84

2.3

—

Other general symptoms and signs

171

2.70

8.83

2.3

2.6

—

Cholecystitis

371

2.12

8.81

2.5

2.4

—

Haemolytic-uraemic syndrome

12.64

8.69

2.6

2.5

—

Dermatopolymyositis

4.68

8.65

2.3

2.6

—

Other abnormalities of plasma proteins

4.67

8.65

2.3

2.4

—

Portal vein thrombosis

4.87

8.64

2.3

—

External causes of morbidity and mortality

579

2197

1.32

8.63

2.5

—

Infections with a predominantly sexual mode of transmission

414

2822

1.37

8.61

2.5

2.6

—

Early onset COPD

139

807

1.73

8.61

2.2

2.3

—

Systemic lupus erythematosus, unspecified

115

3.11

8.60

2.1

2.6

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

398

2513

1.38

8.60

2.5

2.6

—

Emphysema

181

2.62

8.59

2.3

—

Other functional intestinal disorders

285

1812

1.46

8.57

2.4

2.5

—

Other specified/unspecified bacterial intestinal infections

212

2.48

8.48

2.5

2.4

—

Obstructed labour due to malposition and malpresentation of fetus

212

1279

1.56

8.47

2.7

2.5

—

Intestinal stricture

164

1000

1.65

8.44

2.3

2.4

—

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

15.93

8.41

3.4

2.3

—

5-aminosalicylic acid

170

1049

1.63

8.38

2.5

2.6

—

Tuberculosis, IBD comorbidity

144

2.80

8.32

2.1

2.3

—

Need for other prophylactic measures

227

2.41

8.26

2.2

2.5

—

Restrictive cardiomyopathy

18.75

8.25

3.4

1.9

—

Non-allergic asthma (mode), excluding more controls

108

584

1.84

8.22

2.4

2.5

—

Pregnancy hypertension

370

2400

1.39

8.20

2.5

2.6

—

Scleritis

4.67

8.19

1.9

2.7

—

Subjective visual disturbances

179

1126

1.60

8.16

2.4

2.5

—

Caries of dentine, including avohilmo

555

2154

1.32

8.15

2.5

—

Other diseases of anus and rectum

173

1078

1.61

8.11

2.5

—

Viral hepatitis, IBD co-morbidity

254

2.31

8.09

2.7

2.6

—

Other and unspecified immunodeficiencies with predominantly antibody defects

4.27

8.08

2.9

2.5

—

Pain in throat and chest

639

2987

1.29

8.08

2.4

2.5

—

Oxicams

896

0.52

8.07

2.3

2.5

—

Benign neoplasm of other and ill-defined parts of digestive system

101

544

1.87

8.06

2.3

2.4

—

Stomatitis and related lesions

155

945

1.65

8.04

2.4

2.5

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

366

2.07

8.00

2.2

2.4

—

Disorders of optic nerve and visual pathways

462

1.95

7.99

2.3

2.5

—

Other and unspecified drugs and medicaments

340

2.11

7.96

2.1

2.4

—

Dermatopolymyositis (FG)

4.55

7.95

2.3

2.5

—

Sickle-cell disorders

16.87

7.95

1.8

2.8

—

Congenital malformations of the circulatory system

127

714

1.74

7.94

2.6

2.5

—

Other endophthalmitis

11.50

7.93

2.4

3.1

—

Hydrocele

360

2.07

7.93

2.4

2.3

—

Drug-induced osteoporosis with pathological fracture

6.24

7.91

2.7

2.4

—

Other anxiety disorders

433

2800

1.35

7.90

2.6

2.5

—

Traction detachment of retina

7.27

7.89

2.5

2.4

—

Type 2 diabetes, definitions combined

623

2846

1.29

7.87

2.3

2.5

—

Other Crohn's disease

362

2.07

7.87

2.3

2.5

—

Artrosis, including avohilmo

369

2762

0.73

7.86

2.4

—

Pruritus

479

1.92

7.83

2.4

2.5

—

Hypoglycaemia, other or unspecified

290

2.20

7.82

2.4

—

Chronic pancreatitis

396

2.01

7.82

2.3

2.4

—

In situ neoplasms

229

1536

1.50

7.82

2.4

2.5

—

Neurological diseases

759

3033

1.26

7.81

2.4

2.5

—

Keratitis

255

1748

1.47

7.81

2.3

2.5

—

Other disorders of eye and adnexa

120

689

1.76

7.80

2.5

—

Calcific aortic valvular stenosis, operated

112

609

1.79

7.80

2.2

2.3

—

Calcific aortic valvular stenosis

112

609

1.79

7.80

2.2

2.3

—

Calcific aortic valvular stenosis, diagnosis (helper)

111

602

1.79

7.79

2.2

2.3

—

Operations 2 for CAVS

111

602

1.79

7.79

2.2

2.3

—

Excessive attrition of teeth

458

3463

1.33

7.78

2.5

—

Codeine

738

3186

1.26

7.77

2.3

2.5

—

Membranous nephropathy

12.82

7.74

2.5

—

Toxic liver disease

4.43

7.73

2.4

2.5

—

Carcinoma in situ of skin of scalp and neck

4.39

7.71

2.1

2.3

—

Calcific aortic valvular stenosis, including rheumatic fever

111

604

1.79

7.69

2.2

2.3

—

Hyphaema and other vascular disorders of iris and ciliary body

3.79

7.67

2.5

2.4

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

113

3.01

7.62

2.8

2.4

—

Constipation

567

3042

1.29

7.60

2.3

2.5

—

Polyarteritis nodosa and related conditions

4.20

7.60

2.5

—

Use of pramipexole

120

694

1.74

7.59

2.4

—

Other arthritis (FG)

211

1401

1.51

7.58

2.3

2.5

—

Pulmonary oedema

6.26

7.58

2.2

2.7

—

Other disorders starting during childhood or adolecense, excluding more controls

313

2.11

7.55

3.1

2.7

—

Moderate visual impairment, binocular

3.84

7.54

2.2

2.6

—

Other arrhythmias

416

2337

1.35

7.54

2.4

2.5

—

Noninflammatory disorders of female genital tract

397

1459

1.37

7.49

2.6

—

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

188

2.46

7.48

2.2

—

Amyloidosis, other/unspecified

4.48

7.47

3.0

2.3

—

Other and unspecified follicular disorders

189

2.48

7.45

2.1

2.5

—

Non-allergic asthma (mode)

108

604

1.78

7.41

2.4

2.5

—

Abnormalities of heart beat

234

1563

1.47

7.39

2.5

—

Erosion of teeth , including avohilmo

228

1548

1.48

7.39

2.6

—

Acquired absence of limb

8.64

7.39

2.3

2.0

—

Disorders of plasma-protein metabolism, not elsewhere classified

6.58

7.38

2.4

2.8

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

116

568

1.75

7.38

2.2

2.3

—

Pneumothorax

208

2.38

7.36

2.5

2.4

—

Other and unspecified disorders of skin and subcutaneous tissue

202

2.40

7.36

2.4

—

Shock, not elsewhere classified

9.65

7.34

2.1

2.5

—

Misadventures to patients during surgical and medical care

511

1.85

7.34

2.5

2.4

—

Complications following infusion, transfusion and therapeutic injection

4.24

7.32

2.7

2.6

—

Type 2 diabetes, strict (exclude DM1)

626

2890

1.27

7.32

2.3

2.5

—

COPD, hospital admission 2, with asthma infections

143

746

1.65

7.31

2.2

2.3

—

Benign neoplasm: Skin of other and unspecified parts of face

338

2.06

7.31

2.4

—

Exposure to unspecified factor

760

4417

1.24

7.29

2.3

2.5

—

Other disorders of iris and ciliary body

3.27

7.28

2.5

2.4

—

Lichen simplex chronicus and prurigo

197

2.41

7.27

2.5

2.4

—

Kela reimbursement Agammaglobulinemia (D80-84)

4.67

7.27

2.9

2.6

—

Disorders of conjunctiva

646

4123

1.26

7.24

2.5

—

Inflammatory bowel disease

252

1751

1.45

7.24

2.5

—

IBD patients in KELA-register

199

1320

1.52

7.23

2.5

—

Diseases of the ear and mastoid process

942

3885

1.22

7.23

2.4

2.5

—

Disorders of globe

3.73

7.21

2.4

—

Late syphilis

4.02

7.21

2.5

—

Carcinoma in situ of skin of trunk

3.72

7.21

2.4

2.3

—

Other mycoses, not elsewhere classified/unspecified

3.63

7.20

2.7

2.5

—

Acute generalized exanthematous pustulosis

168

2.54

7.20

2.7

2.5

—

Hyperhidrosis

111

2.93

7.19

2.4

2.7

—

Decubitus ulcer and pressure area

133

2.73

7.19

2.4

—

Tuberculosis, wide

162

2.55

7.17

2.1

2.3

—

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

15.13

7.06

2.2

2.1

—

Coxibs

134

1145

0.61

7.05

2.4

2.5

—

Hypoparathyroidism

3.12

7.03

2.4

2.6

—

Other obstructive and reflux uropathy

176

2.48

7.03

2.3

2.5

—

Marginal zone B-cell lymphoma

7.81

6.98

2.1

2.2

—

Disseminated intravascular coagulation [defibrination syndrome]

12.00

6.98

2.4

2.3

—

Inflammatory bowel disease, strict (require KELA)

199

1331

1.50

6.97

2.5

—

Other diseases of lip and oral mucosa

260

1830

1.43

6.97

2.5

—

Malignant melanoma of skin, including Hilmo

324

2.05

6.95

2.3

—

Invasive ventilation

252

2.21

6.95

2.4

2.5

—

Other specified/unspecified arthritis

190

1261

1.51

6.90

2.3

2.5

—

Generalized skin eruption due to drugs and medicaments

160

2.54

6.88

2.7

2.5

—

Chronic myeloid leukaemia

17.63

6.83

2.0

2.5

—

Hypoplasia of dental enamel, prenatal , including avohilmo

6.40

6.82

2.9

2.3

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

169

741

1.57

6.82

2.3

2.2

—

Other nutritional deficiencies

527

3892

1.28

6.80

2.4

2.5

—

Fentanyl

241

2.21

6.77

2.3

2.4

—

Sequelae of cerebrovascular disease

156

854

1.58

6.77

2.2

2.3

—

Scleritis and episcleritis

249

2.19

6.74

2.1

2.5

—

Malignant neoplasm, without specification of site, including Hilmo

3.52

6.71

2.5

2.3

—

Special screening examination for neoplasms

121

2.75

6.70

2.3

2.5

—

Malignant cancer of tonsil and base of tongue, including Hilmo

3.77

6.66

2.2

—

Diseases of the musculoskeletal system and connective tissue

535

2089

1.29

6.65

2.5

2.6

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

9.03

6.63

2.6

2.1

—

Other puerperal infections

113

673

1.70

6.57

2.8

2.7

—

Pain in limb

642

3446

1.25

6.54

2.4

2.5

—

Microscopic polyangiitis

7.81

6.53

2.4

—

Epilepsy

212

1451

1.46

6.53

2.4

2.5

—

Intracerebral haemorrhage

285

2.08

6.51

2.4

2.3

—

Ulcerative colitis

193

1303

1.49

6.49

2.5

—

Paralytic ileus and intestinal obstruction

128

788

1.63

6.45

2.2

2.4

—

Other neurological diseases

405

2422

1.32

6.44

2.4

—

Other specified/unspecified systemic involvement of connective tissue

196

2.32

6.44

2.4

2.5

—

Recurrent and persistent haematuria

5.38

6.42

2.1

2.6

—

Explicit fungal Sepsis

8.51

6.42

2.6

—

Hypertension, Pulmonary Arterial

6.78

6.41

2.6

3.3

—

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

6.78

6.41

2.7

2.5

—

Type 2 diabetes, definitions combined, including avohilmo

627

2921

1.25

6.40

2.3

2.5

—

Acquired pure red cell aplasia [erythroblastopenia]

11.71

6.40

2.2

2.7

—

Benign neoplasm: Colon, unspecified

118

715

1.66

6.36

2.4

2.3

—

Herpesviral [herpes simplex] infections

202

1383

1.47

6.35

2.4

2.6

—

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

5.58

6.33

2.1

2.3

—

Angina pectoris

243

1135

1.43

6.30

2.2

2.4

—

Congenital malformations of heart and great arteries

110

637

1.69

6.26

2.6

2.5

—

Nonhereditary hypogammaglobulinemia

5.19

6.26

2.2

2.6

—

Female infertility, associated with anovulation

119

729

1.65

6.23

2.5

2.7

—

Malignant neoplasm of kidney, except renal pelvis

162

2.42

6.19

2.2

—

Dentofacial anomalies [including malocclusion]

579

3725

1.25

6.18

2.6

2.5

—

Allergic bronchopulmonary aspergillosis (ABPA)

13.27

6.17

2.4

2.5

—

Undetermined asthma, excluding more controls

388

1.89

6.17

2.4

2.6

—

Malignant melanoma

312

2.00

6.15

2.4

2.3

—

Retained placenta and membranes, without haemorrhage

505

1.78

6.13

2.7

2.5

—

Ventral hernia

129

808

1.60

6.11

2.3

2.4

—

Any mental disorder

820

3391

1.21

6.06

2.4

2.5

—

Benign neoplasm: Stomach

260

2.09

6.06

2.2

2.3

—

Diseases of male genital organs

345

1293

1.35

6.04

2.4

2.3

—

Other epidermal thickening

146

2.50

6.04

2.2

2.5

—

Disorders of eyelid, lacrimal system and orbit

556

3373

1.25

6.03

2.4

2.5

—

Open wound of lower leg

106

635

1.68

6.01

2.5

—

Complex cardiac defects

4.24

6.01

3.0

2.6

—

Other benign neoplasms of skin

203

1406

1.45

6.01

2.5

2.4

—

Vascular disorders of the intestines

135

2.54

5.94

2.2

2.4

—

COPD related to multimorbidity

166

931

1.51

5.92

2.2

2.3

—

Nonspecific lymphadenitis

263

2.08

5.91

2.6

2.4

—

Acute bronchiolitis

303

1.95

5.91

2.7

—

Convalescence

148

2.46

5.87

2.8

2.5

—

Ulcerative ileocolitis

192

2.27

5.86

2.2

2.5

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

382

1.88

5.86

3.1

2.6

—

Other disorders starting during childhood or adolescence

358

1.91

5.82

3.1

2.7

—

Malignant neoplasm of head and neck

167

2.35

5.80

2.2

—

Bacterial, viral and other infectious agents

485

1.77

5.78

2.5

—

Benign neoplasm: Sigmoid colon

551

1.71

5.78

2.3

2.4

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

515

1.75

5.78

2.5

2.6

—

Undetermined asthma

397

1.85

5.77

2.4

2.6

—

Chronic hepatitis NAS

4.00

5.76

2.4

2.5

—

Other specified/unspecified necrotizing vasculopathies

5.29

5.74

2.3

2.4

—

Status epilepticus

126

2.57

5.72

2.5

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

364

2711

1.31

5.72

2.4

—

Ocular pain

392

1.85

5.72

2.4

2.5

—

Fracture of foot, except ankle

196

1364

1.44

5.70

2.4

2.6

—

Other aneurysm

132

2.52

5.70

2.5

2.3

—

Other complications of surgical and medical care, not elsewhere classified

378

1.87

5.69

2.4

—

Biliary cirrhosis, NAS

13.89

5.69

2.6

2.1

—

Malignant neoplasm of urinary organs

175

2.30

5.68

2.2

—

Type 1 diabetes, definitions combined

101

606

1.68

5.68

2.4

2.6

—

332

2497

1.32

5.67

2.5

—

Other proliferative retinopathy

8.94

5.65

2.2

2.7

—

Hypothyroidism, strict autoimmune

517

2711

1.26

5.63

2.5

—

Amyloidosis

3.59

5.63

3.0

2.3

—

Drug-induced adrenocortical insufficiency

3.46

5.62

2.1

2.4

—

Glaucoma suspect

164

1105

1.49

5.62

2.3

—

Underdevelopment of the second kidney

18.68

5.62

2.0

3.0

—

Infarction of spleen

10.40

5.59

2.2

2.7

—

Other systemic involvement of connective tissue (FG)

147

957

1.52

5.58

2.3

2.5

—

Small fibre neuropathy

2.89

5.54

2.6

2.3

—

Bacterial, viral and other infectious agents

440

1.79

5.54

2.5

2.4

—

Alport

13.26

5.53

2.0

3.6

—

Kela-code for severe mental illness

140

2101

0.66

5.52

2.2

2.5

—

Malignant cancer of tonsil and base of tongue

3.68

5.51

2.2

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

222

1591

1.40

5.49

2.5

—

Adrenocortical insufficiency

123

2.55

5.48

2.2

2.6

—

Prurigo nodularis

3.28

5.47

2.1

2.4

—

Macular pucker

327

1.91

5.42

2.2

2.3

—

Lung diseases due to external agents

377

1.84

5.41

2.3

2.4

—

Other diseases of gallbladder

118

2.57

5.38

2.1

2.4

—

Soft tissue disorders

836

3609

1.19

5.36

2.4

2.5

—

Unspecific neurodegenerative disorder

592

0.48

5.34

2.0

2.3

—

Nail disorders

365

1.85

5.34

2.2

2.4

—

Crohn disease

116

735

1.59

5.33

2.4

2.5

—

Other condition

110

688

1.61

5.32

2.5

2.4

—

Intrahepatic Cholestasis of Pregnancy (ICP)

469

1.75

5.29

2.5

2.7

—

Type of accident

202

1435

1.41

5.28

2.4

2.5

—

N06DA Anticholinesterases

491

0.40

5.26

2.0

2.2

—

Use of anticholinesterases

491

0.40

5.26

2.0

2.2

—

Infection due to other mycobacteria

5.49

5.25

2.4

2.3

—

Cryoglobulinemia

15.16

5.24

2.5

3.0

—

Cystic fibrosis, other manifestations/unspecified

15.12

5.24

2.3

3.2

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

216

1555

1.39

5.22

2.5

—

Drug-induced hypoglycaemia without coma

3.54

5.20

2.2

2.5

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

486

1.72

5.20

2.9

2.6

—

Obsessive-compulsive disorder

472

1.73

5.18

2.6

—

Cystic fibrosis

14.43

5.18

2.3

3.2

—

Finngen Rheumatological endpoints

760

3613

1.20

5.16

2.4

2.5

—

Familial hypercholesterolemia

340

1.86

5.15

2.2

2.4

—

Urticaria and erythema

278

2087

1.34

5.15

2.5

—

Basal cell carcinoma, including avohilmo

161

751

1.48

5.12

2.3

2.2

—

Acute pharyngitis

151

1014

1.49

5.12

2.6

—

Xerosis cutis

3.82

5.12

2.1

2.5

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

429

1.77

5.12

2.4

2.6

—

Other viral hepatitis

342

1.86

5.11

2.7

2.5

—

Adverse effects, not elsewhere classified

162

1113

1.46

5.10

2.4

2.6

—

Type 1 diabetes, strict (exclude DM2)

100

617

1.63

5.09

2.4

2.6

—

Malignant neoplasm of other connective and soft tissue

3.60

5.06

3.2

2.3

—

Lupus nephritis

7.33

5.05

2.0

2.9

—

Open wound of ankle and foot

498

1.70

5.04

2.3

2.5

—

Special screening examination for other diseases and disorders

357

1.83

5.04

2.7

2.5

—

Polyuria

112

715

1.57

4.98

2.4

—

Rosacea

492

1.70

4.98

2.4

2.5

—

Other diseases of oesophagus

253

1.99

4.97

2.1

2.3

—

Primary hyperparathyroidism

274

1.95

4.96

2.4

—

Abnormal findings in nipple discharge synovial fluid wound secretions

3.19

4.95

2.4

2.6

—

Other meningitis

3.18

4.94

2.5

2.6

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

207

2.11

4.93

3.1

2.5

—

Maternal care for cervical incompetence

174

2.21

4.93

2.9

2.5

—

Stroke, excluding SAH

275

1506

1.34

4.91

2.3

—

Corneal ulcer

133

886

1.51

4.90

2.4

2.5

—

Cyst of kidney

181

2.17

4.87

2.1

2.4

—

Basal cell carcinoma

151

707

1.48

4.85

2.3

2.2

—

Other systemic involvement of connective tissue

151

1034

1.47

4.85

2.4

2.5

—

Duodenal ulcer

235

2.01

4.83

2.2

2.4

—

Melanocytic naevi of lower limb, including hip

189

2.14

4.81

2.9

2.5

—

Episodal and paroxysmal disorders

863

3731

1.18

4.80

2.4

2.5

—

Polymyositis

5.91

4.80

2.2

2.3

—

Obesity related asthma

212

1545

1.38

4.80

2.3

2.5

—

Other retinal artery occlusion

3.62

4.78

2.6

2.4

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

251

1858

1.34

4.78

2.4

2.5

—

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

2.85

4.76

2.2

2.7

—

Schizophrenia

836

0.51

4.76

2.3

2.4

—

Pneumonia derived septicemia

126

2.41

4.74

2.3

2.4

—

Coronary artery bypass grafting

435

1.63

4.73

2.3

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

157

1092

1.45

4.69

2.6

—

Neuromuscular dysfunction of bladder

294

1.88

4.68

2.4

—

Pain in joint

415

2106

1.26

4.66

2.3

2.5

—

Helminthiases

205

2.08

4.66

2.8

2.6

—

Other and unspecified glaucoma

146

2.27

4.63

2.2

2.3

—

Tonsillectomy and adenotomy

540

3088

1.22

4.60

2.6

2.5

—

Irregular menses

408

2575

1.25

4.59

2.6

—

Twin gestation

451

1.70

4.58

2.5

—

Congenital vesicoureteral reflux

3.42

4.55

3.2

2.6

—

Other disorders of breast and lactation associated with childbirth

142

2.31

4.54

3.1

2.7

—

Obesity

483

3808

1.23

4.54

2.3

2.5

—

Obesity and other hyperalimentation

484

3812

1.23

4.53

2.3

2.5

—

Essential (haemorrhagic) thrombocythaemia

2.74

4.52

2.2

2.5

—

Abnormal findings on diagnostic imaging of central nervous system

194

2.08

4.51

2.8

2.5

—

Cerebral aneurysm, nonruptured

277

1.89

4.49

2.4

—

Suppurative and unspecified otitis media

346

2415

1.27

4.49

2.5

2.6

—

Postmenopausal osteoporosis with pathological fracture

2.66

4.49

2.2

—

Campylobacter enteritis

105

2.51

4.49

2.2

2.5

—

Infections of genitourinary tract in pregnancy

554

1.62

4.48

2.6

—

Retention of urine

158

906

1.43

4.47

2.3

2.4

—

Artificial opening status

2.54

4.46

2.8

2.3

—

Liver disorders in diseases classified elsewhere

8.07

4.45

2.0

2.9

—

Intracranial and intraspinal abscess and granuloma

4.17

4.45

2.3

2.4

—

Myocardial infarction, unclassifiable

390

1.70

4.44

2.4

2.2

—

Adult respiratory distress syndrome

4.15

4.44

2.5

—

Other inflammation of eyelid

524

1.63

4.43

2.5

2.4

—

Injuries to unspecified part of trunk, limb or body region

433

1.70

4.42

2.2

2.4

—

Other abnormal findings of blood chemistry

169

2.15

4.42

2.6

2.5

—

Tongue abnormality

189

2.08

4.41

2.4

2.5

—

386

2789

1.25

4.41

2.3

2.5

—

Acute suppurative otitis media

276

1978

1.31

4.41

2.5

2.6

—

Recurrent aphthous stomatitis , including avohilmo

102

658

1.56

4.40

2.4

2.5

—

Malignant melanoma of skin

244

1.94

4.38

2.4

—

Other external causes of accidental injury

657

2755

1.20

4.37

2.4

2.5

—

Toxic encephalopathy

12.68

4.37

2.0

2.8

—

Cytomegaloviral hepatitis

9.55

4.37

2.0

2.6

—

Viral hepatitis

375

1.75

4.36

2.7

2.5

—

Monocytic leukaemia

9.41

4.35

4.0

2.3

—

Pain associated with micturition

435

1.69

4.35

2.5

2.4

—

Other, unspecified and serous retinal detachments

2.68

4.34

2.2

2.3

—

Infections of breast associated with childbirth

253

1.93

4.33

2.6

—

Use of donepezil

282

0.30

4.32

1.9

2.2

—

Retinal breaks without detachment

489

1.64

4.32

2.4

2.3

—

Multiple gestation

467

1.66

4.30

2.5

—

Mixed connective tissue disease

232

1.96

4.30

2.4

—

Abnormality of white blood cells, not elsewhere classified

4.63

4.29

2.9

2.8

—

Obesity due to excess calories

364

2907

1.26

4.28

2.3

2.5

—

Viral infections of the central nervous system

333

1.79

4.27

2.3

2.4

—

Macular cyst

2.87

4.24

2.1

2.3

—

Short stature, not elsewhere classified

147

2.19

4.22

2.8

2.7

—

Alcohol use disorder, Swedish definition

355

2592

1.26

4.22

2.3

2.5

—

Other bacterial agents as the cause of diseases classified to other chapters

3.34

4.22

2.3

2.7

—

Malignant neoplasm, without specification of site

3.88

4.20

2.1

—

Other female pelvic inflammatory diseases

642

1.55

4.19

2.6

2.5

—

Gangrene, not elsewhere classified

7.11

4.19

2.1

2.2

—

Nonalcoholic steatohepatitis

4.48

4.17

2.2

2.7

—

Placenta praevia

228

1.95

4.17

2.7

2.5

—

Polyarteritis nodosa

6.07

4.17

2.6

2.7

—

Dementia, including avohilmo

747

0.60

4.15

2.2

2.3

—

Other predominantly sexually transmitted diseases, not elsewhere classified

172

1246

1.39

4.13

2.4

2.6

—

Orchitis and epididymitis

307

1.80

4.13

2.5

2.3

—

8.46

4.13

2.3

2.5

—

Chronic diseases of tonsils and adenoids

633

3370

1.19

4.12

2.5

—

Crohn's disease (strict) with PSC

10.97

4.11

2.6

2.4

—

Injuries to the ankle and foot

559

4160

1.20

4.09

2.4

2.5

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

110

2.39

4.08

2.4

2.6

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Toxoplasma gondii IgG Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS